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A B S T R A C T
The main processes involved in skin aging are intrinsic and extrinsic. Apart from them, so called stochastic aging
connotes cell damage caused by metabolic processes, free radicals and cosmic irradiation. The clinical expression of in-
trinsic aging include smooth, dry, and thinned skin with accentuated expression lines. It is inevitable and time depend-
ent. Extrinsically aged skin shows signs of photodamage which include appearance of wrinkles, pigmented lesions, ac-
tinic keratoses and patchy hypopigmentations. Therapeutic modalities imply photoprotection with sunscreens that
prevent sunburns and block ultraviolet irradiation. Other modalities include use of retinoids which regulate gene tran-
scription with subsequent cellular differentiation and proliferation. The topical and peroral administration of »network
antioxidants» such as vitamin E and C, coenzyme Q10, alpha-lipoic acid and glutathione, enhance antiaging effect. The
other antioxidants such as green tea, dehydroepiandrosterone, melatonin, selenium and resveratrol, have also antiaging
and anti-inflammatory effects. Topical bleaching agents such as hydroquinone, kojic acid and azelaic acid can reduce
signs of aging. Studies confirm the efficacy of these topical agents in combination with superficial and/or medium depth
or deep peeling agents for photodamaged skin treatment. Indications for type of chemical peels according to various clin-
ical diagnosis are done, as well as advantages and disadvantages of differetn types of chemical peels.
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Introduction
More scientific data about antiaging has radically
changed in the last decade. New discoveries contribute to
efforts for making younger-looking skin. A youthful
healthy appearance seems to be very important in mod-
ern society. So, many people feel anxiety about visible
signs of aging and consequently seek dermatologic ad-
vice. These days, American women spend around 5 bil-
lion dollars a year on skin care products1. This genera-
tion of baby boomers have very proactive approach to
reduce the signs of aging2. Due to better social, economic
and healthy conditions, it is estimated that in the next 50
years, about one-third of women will be menopausal1. So,
anti-aging medicine is of great importance3. Many people
prefer a more economical or less invasive approach than
for example botulinum toxin A, soft tissue augmentation
and laser or chemical resurfacing. These less invasive
treatments imply so called »cosmeceuticals« which have
biologically active ingredients. The cosmeceutical phe-
nomenon has had a deep impact on the beauty industry
and also on dermatological practice2. From a regulatory
perspective, cosmeceuticals do not really exist. It is a
term used primarily for marketing purpose by cosmetic
producers, because they can not claim drug-like ingredi-
ents for their product. Nowdays, cosmeceutical prepara-
tions contain a large list of »active ingredients« (Table
1)2. Majority of these substances do not fulfil Kligman’s
definition of efficacy such as proof of penetration, mode
of action and evidence of clinical value. The ideal cosme-
ceutical product would mean that it has immediate and
long-lasting results, as well as low side effect, good com-
pliance which include good texture, pigmentation, laxity
and easy applicability. It is important to point out that
preventive benefits are also of great importance2.
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Skin aging
All humans experience intrinsic aging. It is the result
of accumulation of endogenous reactive oxygen species
(ROS) and is time dependent. Reactive oxygen species
damage cellular tissue and constituents such as lipid
membranes, cellular enzymes and DNA. In the same
time, it has strong genetic background and it is also un-
der influence of decreasing sex hormone levels, though,
premature facial wrinkling in women does not respond to
hormone replacement therapy3–5. It seems that telome-
res, terminal portion of eukariotic chromosome, which
shortens with successive cycles of replication with subse-
quent progressive erosion, play very important role3,6.
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TABLE 1
COMMON AGENTS USED IN COSMETEUTICALS
Category Ingredients
Vitamins Vitamin A (retinoic acid) Vitamin E(alpha tocopherol)
Vitamin B Retinaldehide
Vitamin B3 (niacinamide) Retinol
Niacinamide (nicotinamide) panthenol Retinyl acetate
Pro-vitamin B5 (panthenol) Retinyl esters
Beta caroten Retinyl palmitate







Antioxidants Alpha-lipoic acid (ALA) Glutathione
Catalase Idebenone
Dimethylaminoethanol (DMAE) Ubiquinone
Hydroxy acids Alpha-hydroxy acids (glycolic,lactic,malic acids) Lanolin
Beta hydroxy acids (salicylic acid) 4-Oxo-retinoic acid
Dihydroxyacetone Polyhydroxy acids (gluconolactone, lactobionic acid)
4-Hydroxy-retinoic acid Salicylic acid
Lipids Glucosylceramide
Glycosaminoglycans Hyaluronic acid







Ceramides Tea tree oil






Pigment lightening Azelaic acid
agents Hydroquinone
Kojic acid





During skin aging, modifications of growth factors and
hormones that decline, especially sex steroids such as es-
trogen, testosterone, dehydroepiandrosterone (DHEA)
and its sulfate ester (DHEAS), as well as melatonin, in-
sulin, cortisol, thyroxine and growth hormone, occur3,7–9.
The levels of certain signaling molecules as cytokines
and chemokines also diminish as well as the quantity of
their receptors, yet the other molecules increase such as
transforming growth factor-beta1, which induces fibro-
blast senescence10. These changes lead to different cellu-
lar response with subsequent decreased viability to exoge-
nous factors or consecutive cell death11. Aged skin shows
its characteristic such as dryness, atrophic changes, smo-
othness and laxicity. The histological appearance reveals
no changes in stratum corneum and epidermis, keratino-
cyte shape and their adhesion. The number of melano-
cytes and Langerhans cells is decreased5. The dermo-
epidermal junction is flattened with reduced surface con-
tact between epidermis and dermis. As a result, exchange
of nutrients and metabilites is reduced5,12. Blood supply
is also decreased13.
Extrinsic aging develops due to long-term ultraviolet
(UV) and ionizing radiation, severe physical and psycho-
logical stress, alcohol abuse, poor nutrition, over-eating,
environmental pollution and other agents. UV radiation
shares 80% in extrinsic aging. It is the most important
factor in premature aging4,14.
The most of UVB (290–320 nm) rays are absorbed in
the dermo-epidermal level. They damage DNA in kera-
tinocytes and melanocytes. They are responsible for ery-
thema, sunburn, DNA damage, hyperpigmentation, len-
tigines and occurrence of actinic keratoses and skin
cancer. Acronymus for UVB damage is B like burn, bad
or bronzing.
On the other hand, UVA rays (320–400 nm) are more
abundant in the atmosphere than UVB and are absorbed
into the deeper part of dermis. So, they damage epider-
mis and dermis as well. It is well known that UVA radia-
tion plays the most important role in pathogenesis of
photoaging, although the mode of action remains un-
clear. So, the acronymus for UVA damage is A like aging
or allergy14,15. Photoaged skin is characterized by alter-
ations in dermal connective tissue such as strengthening
and elastin substances accumulation16–18.
Clinically photodamaged skin presents with coarse
and fine wrinkling, motted pigmentary changes, textural
roughness, and teleangiectasis. Histological changes of
photoaged skin include significant epidermal and dermal
alterations with increased or decreased epidermal thick-
ness, loss of polarity of keratinocytes and their atypia. In
the dermis elastosis, degeneration of collagen fibriles ap-
pear. Blood vessels become dilated. Ultraviolet exposure
activates degrading enzyme for collagen and elastic tis-
sue such as matrix metalloproteinases (MMPs). Cyto-
kines are released from keratinocytes, and cumulative ef-
fect of these changes is chronic dermal inflammation15,19,20.
The induction of MMPs can be reached within minutes
after UVB radiation. Pretreatment of the skin with tre-
tinoin during autumn, winter and early spring period in-
hibits activation of MMPs in UVB exposed skin21.
Smoking is very important factor of premature aging.
It activates production of MMPs with subsequently »smo-
ker’s face» or »cigarette skin». The skin is characteristi-
cally ashen and shows grey colour with increased num-
ber of wrinkles22–24. Corneal layer is also reduced, as well
as quantity of A vitamin4,25,26. Chemical compounds such
as nitrogen oxides or organic compounds from fuel com-
bustion together with UV irradiation also are responsible
for skin damage27.
In the skin there are also natural protectives such as
melanin in lower part of epidermis and the protein-
-urocanic acid in stratum corneum. They absorb and re-
flect significant amount of UVB irradiation. It seems
that thickness of stratum corneum is more important for
photoprotection than pigmentation or total thickness of
epidermis28.
Photoaging affects all races and skin types. The mani-
festation of photodamage may differ in lighter skin types
compared with darker ones. Persons with fair skin and
hair (type I, II and III according to Fitzpatrick) will ob-
tain much more degenerative changes than type IV and
V, because their melanosomes in higher parts of epider-
mis and corneal layer more efficiently protect epidermal
and dermal structures from UVA and UVB. In contrast
to lighter skin types, clinical experience document that
persons with dark skin show less wrinkling than li-
ghter-skinned individuals29–33. Clinical photodamage in
black skin appears to be a subtle phenomenon which
manifests as diffuse or patchy hyperpigmentation and
texturally rough skin. Also, there is significantly lower
incidence of skin cancer among this population34,35. Since
the number of melanocytes decreases every 10 years for
8–20%, photoprotection is recommended, especially in
older persons3.
The degree of photodamage is classified according to
Glogau based on the extent of skin changes. There are
four degrees ranging from mild, moderate, advanced and
severely photodamaged changes. Depending upon degree
of damage, anti-aging treatment can be recommended3,34,36.
Mild photodamage will respond to topical anti-aging pro-
ducts and superficial chemical peels. Moderate to ad-
vance photodamage has excellent response with medium-
-depth peel. Severe photodamage requires medium-depth
or deep peeling procedures in combination with lifting or
rhytidectomies37.
Therapeutic Modalities
Topical therapeutic modalities imply photoprotection,
use of retinoids and topical antioxidants such as C vita-
min, bleaching agents and peels with alpha-, beta- and
polyhydroxy acids. Resurfacing procedures are microder-
moabrasion, superficial chemical peeling, medium-depth
peeling, ablative and non-ablative laser resurfacing, ra-
dio frequency therapy and face lifting procedures (Table
2)1.
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Photoprotection
Photoprotection means avoidance of sun exposure
when it is possible by wearing protective clothing, glasses
and daily use of sunscreens3,4,38–41. Sunscreens are the
gold standard for skin protection from UV rays. They
were initially synthesized to prevent UVB induced sun-
burns. But in the last 10–15 years, agents have been for-
mulated that can absorb and/or block UVA irradiation39.
Sun-protecting agents are classified as organic or physi-
cal blocking agents. Organics agents protect by absorbing
UVA and/or UVB rays. Chemical ingredients in sunscreens
are: octyl-dimethyl-PABA (UVB), 2-ethylhexyl-p-metho-
xycinnamate (UVB), octocrylene (UVA/UVB), octyl saly-
cilate (UVB), benzophenones (UVA/UVB), and methyl
anthranilate (UVA). Avobenzone or Parsol 1789 block
UVA, but can induce photoallergic reaction. Many pro-
ducers combine ingredients in order to maximize photo-
protection1,39. Their combination in the same product
renders the whole filter system photo-unstable which
means that UV exposure causes photochemical reactions
that generate ROS with subsequent phototoxic and pho-
toallergic reactions1,3. The great efforsts have been made
to stabilize molecules in UV filters1,3. The sunscreen in-
gredients should absorb or reflect and scatter during the
period of photo-protection, and thus should remain sta-
ble photochemically. Many chemical filters have some
photoreactivity, leading to formation of photoproducts
that might act as a light filters. Photostability depends
on the filter itself, on the presence of other filters in the
product and on solvents or vehicle. Many UV filters such
as avobenzone octinoxate and octyl dimethyl PABA, are
photolabile. Other UV filters are frequently used in the
sunscreens as they are known to increase the photo-
stability of the final product. These agents are zinc and
titanium oxide, the salicylates and methylbenzylidene
camphor. There are some new agents that are photo-
stable such as terephthalylidene dicamphor sulphonic
acid (Mexoryl SX) drometriazole trisiloxane (Mexoryl
XL), methylenebis-benzotriazoyl tetramethylbutylphenol
(Tinosorb M) and bis-ethyl-exyloxyphenol methoxyphe-
nol triazine (Tinosorb S)39. Mexoryl is the most efficient
chemical blocking agent for UVA38,39. They reflect UVA
and UVB. Applied on the skin, they induce white or
ashen color, so called »ghost« effect which is for the most
patients unacceptable3,4,42. Nowdays, micronized formu-
lations of these agents are available with subsequent
much more better compliance by the patient. Sunscreens
must be used weeks before and months after chemical
peeling procedures4.
Retinoids
Initially, the definition of retinoid was a compound
whose structure and action resembled the parent com-
pound, vitamin A. Last several decades, chemists made
extensive modifications of the molecule that resulted in
the development of three generations of retinoids (Table
3)4. There are over 125 distinct dermatologic disorders
for which there is credible evidence of retinoid efficacy43.
The latest retinoids bear little structural resemblance to
retinol but they are qualified as retinoids because they
share one or more functions with the parent compound.
Retinoids mediate cellular response through regulating
gene transcription and affecting activities such as cellu-
lar differentiation and proliferation4. They activate two
types of nuclear retinoid receptors: the retinoic acid re-
ceptors (RARs), and retinoid X receptors (RXRs). Each of
them contain three subtypes: alpha, beta and gamma4,44,45.
All of these receptors are members of a large superfamily
called nuclear hormone superfamily receptors which in-
cludes receptors for vitamin D, estradiol, glucocorticoids
and thyroid hormone. Ninety percent of the RARs in the
epidermis are RAR, which are receptors responsible for
terminal differentiation. So, they are target used in der-
matology4. Recent evidence suggest that aside of its ther-
apeutic role, retinoids also prevent photoaging because of
N. Puizina-Ivi} et al.: Topical Treatment of Aging Skin, Coll. Antropol. 34 (2010) 3: 1145–1153
1148
TABLE 3
THREE GENERATIONS OF RETINOIDS FOR THE TOPICAL
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its inhibitory effects on MMPs. Pretreatment of the skin
with topical retinoids was shown to inhibit loss of pro-
collagen synthesis4. Among commonly prescribed drugs
retinoids, such as tretinoin activates the RARs (,  and
) directly, and RXRs indirectly. On the other hand,
tazarotenic acid, the tazarotene metabolite, binds selec-
tively to RARs ( and ), and is unable to directly or indi-
rectly activate RXRs46,47. Consequently, it is likely to be
less irritating than tretinoin48. The difference in their ac-
tivity can explain the varying efficacy of different reti-
noids in topical dermatologic therapy. It is also important
to emphasize that retinoids increase the depth and pene-
tration of peeling agent38. Several studies documented
the efficacy and safety of tretinoin in treatment of pho-
todamage49–51. There are two concentrations: 0.1% and
0.025%, and there is no difference in these two formula-
tions concerning the improvement of skin aging, but
0.1% produces higher degree of irritation38. Skin treated
with 0.1% tretinoin showed increase in type I collagen
formation in comparison with skin treated with vechicle.
With colorimetric analysis, significant lightening of hy-
perpigmentation after tretinoin treatment was demon-
strated38. Tazarotene is synthetic retinoid, pro-drug of
tazarotenic acid which is effective for photodamaged
skin. It improves wrinkling, lentigines, elastosis, irregu-
lar depigmentation and roughness like tretinoin does44.
Retinoids are also well tolerated in dark pigmented skin,
but they may cause post-inflammatory hyperpigmenta-
tion, although hyperpigmentation can occur after treat-
ments with retinoids without evidence of irritation38.
Retinol is also a first generation retinoid, that must
be converted to retinaldehyde and then to all-trans re-
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TABLE 4




Glycolic acid – very mild erythema
– mild desquamation
– short post–operative period
– neutralization is mandatory
– burning sensation and erythema during application
– no uniformity of application
– necrotic ulceration depend upon the time of
application
– cautions in patients with active acne
Jessner’s solution – excellent safety profile
– all skin types (III and IV)
– enhance penetration of TCA
– resorcinol toxicity (thyroid dysfunction)
– manufacturing variations
– instability with exposure to light and air
– increased exfoliation in some patients, scarring
Pyruvic acid – very mild erythema
– mild desquamation
– short post-operative period
– all skin types (III and IV)
– neutralization is mandatory
– intense burning sensation during application
– irritating vapors for upper respiratory mucosa
Resorcinol – easy to perform
– uniformity of application
– uniformity of penetration
– useful in acne, melasma
– useful against postinflammatory hyperpigmentation
– not painful
– desquamation is aesthetically unacceptable
– unsafe in dark skin type
– is not used in summer
– might be a sensitizing and toxic agent
Salicylic acid – safety profile for types I–VI
– excellent for acne patients
– white precipitation
– an anesthetic effect
– subsequent better tolerance
– limited depth of peeling
– minimal efficacy in significant photodamage
– scaling
Tricloracetic acid – low-cost procedure
– uniformity of application
– uniformity of penetration
– easy modulable
– burning and stinging sensation during application
– high concentrations not good in skin types V and VI
– hypo/hyperpigmentation can occur
– scaring
– no neutralisation possible
Phenol – useful in severe photodamage
– useful for deep wrinkles
– useful for atrophic acne scars
– for facial rejuvenation – the strongest option
– cardiotoxicity, nephrotoxicity
– hypopigmentation after repeated procedures
– stand-by anaesthesist
– demarcation lines
tinoic acid within keratinocytes to become active52. To-
day it is classified as a cosmetic substance rather than
drug. It is now found in many over-the-counter for-
mulations53. Patients treated with retinol products were
said to have significant improvements in skin texture,
clarity and hyperpigmentation. Application of retinol
produces histologic and molecular alteration that is very
similar with results after retinoic acid application53.
Antioxidants
In cosmetic industry there are lot of antioxidants,
which are used for protective role enhancing antiaging
effect, but the most currently used in cosmetic industry
are »network antioxidants«. They are used because they
work synergistically and regenerate and enhance the
power of each other54. The five network antioxidants
known at this time are vitamins C and E (tocopherol),
glutathione, lipoic acid and coenzyme Q10 (ubiquinone).
Vitamin C or coenzyme Q10 can recycle vitamin E, do-
nating electrons to vitamin E to return the compound to
its antioxidant state. Vitamin C and glutathione are recy-
cled by lipoic acid or vitamin C4. Antioxidants are divided
in three groups: fat-soluble, water-soluble and fat- and
water-soluble antioxidants55.
Fat-soluble antioxidants are found in the lipophilic
portion of the cell membrane and include vitamin E and
coenzyme Q10. Vitamin E is found in vegetables, oils,
seeds, nuts, corn, soy, whole wheat flour, margarine and
some meat and dairy products. Protective effect of orally
administered vitamin E is achieved with 22–400 IU daily.
The potency of vitamin E is increased through combina-
tion with other antioxidants. Side effects of topically ap-
plied vitamin E are contact dermatitis, papular and folli-
cular lesions, contact urticaria, eczematous dermatitis
and erythema multiforme-like reactions. Vitamin E has a
blood-thinning effect, and patients on anticoagulant the-
rapy should avoid high doses of vitamin E55. Coenzyme
Q10 is found in fish and shellfish. The current recom-
mended oral dose is 90–150 mg daily. Oral Q10 supple-
mentation is associated with caffeine-like side effects and
may cause nervousness, diarrhea and insomnia. So, it is
recommended that Q10 should not to be taken at night56.
The antioxidant known to be soluble in water and fat
is lipoic acid (formerly called thioctic acid). It is essential
co-factor in mitochondrial dehydrogeneses57. It is a po-
tent antioxidant and systemically administered influ-
ences in the glucose control preventing chronic hypergly-
cemia-associated complications such as diabetes mellitus,
Alzheimer disease, cataracts, HIV activation and radiation
injury4,59. It is suggested to use 25–500 mg daily4,58,59.
Water soluble antioxidants are found in hydrophobic
areas of the cell and the serum. They are vitamin C
(ascorbic acid) and glutathione. Glutathione is the most
abundant antioxidant in the »network«. It is produced
from aminoacids as glutamic acid, cysteine and glycine.
Oral glutathione is not well absorbed in the body, and
supplementation is difficult and not available. The other
antioxidant vitamin C is well known. Oral vitamin C is
associated with decreasing risk of certain cancers, cardio-
vascular disease and cataracts and with improving wound
healing and immune modulation60. Unfortunately, there
are no studies that demonstrate that ingestion of oral C
vitamin increase the levels of vitamin C in the skin4.
Topically administered vitamin C prevents some effects
of sun damage and is applied for the treatment of me-
lasma and reduction of postoperative erythema in laser
patients61. But it must be stressed that topical vitamin C
products must be formulated properly and stored in
light-resistant containers to be effective. Ascorbic acid
can be formulated into water- or lipid-soluble forms. A
lipid form of topical ascorbyl palmitate, is nonirritating
and anti-inflammatory, but many available topical prepa-
rations are unable to penetrate the stratum corneum due
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TABLE 5
INDICATIONS OF CHEMICAL PEELS ACCORDING TO VARIOUS
DIAGNOSIS
Diagnosis Type of chemica peel
Photoaging Mild to moderate:
– glycolic acid 50–70%
– trichloracetic acid 50%
– salicylic acid 20–30%
– salicylic acid 25% + trichloracetic
acid >25% gel
Severe:
– glycolic acid 70% + trichloracetic
acid 35%
– Jessner’s solution + trichloracetic
acid 35%
– pyruvic acid 60–70%
– phenol 45–80%
Solar lentigines – trichloracetic acid >25%
– salicylic acid 25% + trichloracetic
acid 25–30% gel
– pyruvic acid 50–70%
– phenol 45–80%
Actinic keratoses – trichloracetic acid >30%
– pyruvic acid 50–60%
– salicylic acid 25% + trichloracetic
acid 25–30% gel
Melasma – salicylic acid 25%
– salicylic acid 25% + trichloracetic
acid 10% gel
– trichloracetic acid 15–20%
– pyruvic acid 40–50%




– salicylic acid 20–30%
– glycolic acid 70%
– Jessner’s solution
– pyruvic acid 40%
Rosacea Erythrosis:
– salicylic acid 15–25–30%
Papulo-pustular rosacea:
– salicylic acid 25–30%
to lipophobic nature of vitamin C4. The problem with vi-
tamin C is also lack of stability after opening of container
and contact with air and UV radiation, so, the most of
preparations become inactive within hours of opening
the bottle4. Oral supplements are superior. As vitamin C
improves existing wrinkles, the mechanism must be rat-
her its effect on collagen synthesis than its antioxidant
effects4,62.
In the group of other antioxidants, there are green
tea, dehydroepiandrosterone (DHEA), melatonin, sele-
nium and resveratrol. Green tea is a popular beverage in
Asian countries. The antioxidant effects of green tea are
due of the polyphenolic compounds contained. They are
known as epicatechins. Polyphenols are molecules with
two adjacent hydroxyl groups on a benzol ring. They are
found in numerous foods like white and red wine, black
or the before mentioned green tea, fruits (extract from
grape seeds) and vegetables1. Topically or orally adminis-
tered they inhibit chemical carcinogens or UV induced
skin carcinogenesis and have anti-inflammatory effects63,64.
DHEA is belived to be the potent antioxidant, but its an-
tioxidant abilities still have to be proven. It stimulates
the immune system. Secretion of DHEA and its sulfate
ester decrease with age. Patients treated with DHEA ex-
perienced increase sebum production, skin surface hy-
dration, epidermal thickness and decreased facial pig-
mentation. Because it is a new product among the anti-
aging treatment options, little is known about the effects
of long term use. Endogenous DHEA concentrations
reach peak at age 20 to 30 years. So, use of DHEA in the
age under 35-year has some risk. A manic episode in a
young man is recorded4. Melatonin is hormone, which is
secreted by the pineal gland. It is a free radical scavenger
and increases the efficacy of other antioxidants. It pro-
tects membrane lipids and nuclear DNA from ROS oxi-
dative damage. It is available in an oral form, but not
topically62,4. Resveratrol is a polyphenolic phytoalexin
compound found in the skin and seeds of grapes, pea-
nuts, berries and red wine. It exists in two isomeric
forms: trans-resveratrol, that is more stable form, and
cis-resveratrol. It has antiproliferative and anti-inflam-
matory properties against various cancers, including
skin cancer. It has inhibitory effect on events associated
with tumor initiation, promotion and progression by
triggering apoptosis in tumor cells4. It seems that data
and clinical evidence are promising to regard resveratrol
in various products such as emollients, patches, sun-
screens and other skin care products4.
Bleaching agents
Topical bleaching agents include hydroquinone, kojic
acid, azelaic acid, and agents that are added to cos-
meceuticals such as arbutin, licorice, soy extract, ellagic
acid, resveratrol and unsaturated fatty acids65.
Hydroquinone is a very effective bleaching agent used
in the tretment of post-inflammatory hyperpigmentaion,
melasma, photoaging, freckles and lentiginosis. It is of-
ten used in combination with retinoids and chemical
peeling agents in order to reverse signs of photoaging38.
It inhibits tyrosinase and prevents conversion of tyrosine
to DOPA66,67. Long-lasting repeated application can dam-
age melanosomes as well as melanocytes66. It is usually
well tolerated in concentrations of 2%. In Europe it is
rarely sold in concentration of 4% without prescription68.
A very potent formulation based on combination of 4%
hydroquinone, 0.05% tretinoin and 0.01% fluocinolone
improves signs of photoaging and post-inflammatory hy-
perpigmentation4. Side effects of hydroquinone treat-
ment might be acute or chronic. Acute reactions are al-
lergic contact and irritant dermatitis with subsequent
temporary post-inflammatory hyperpigmentation. A
chronic side effect is ochronosis in dark skinned patients
characterized by reticulated hyperpigmentation of the
face. It is often permanent69.
Kojic acid is a fungal derivative that inactivates tyro-
sinase by chelation of copper, but it is less effective than
hydroquinone. It is often used in concentration of 2 to
4%. It can be used in combination with retinoids and
glycolic acid usually in patients who do not tolerate
hydroquinone, or after longterm teatment with hydro-
quinone38.
Azelaic acid was created for acne treatment, but it
showed quite mild therapeutic effect in treatment of
hyperpigmentation, freckles and lentigines. Its effect is
probably mediated by inhibition of mitochondrial oxydo-
reductase activity and DNA synthesis as well as by dis-
turbing of tyrosinase synthesis. It might be used in pa-
tients sensitive to hydroquinone4.
Chemical peels
According to the degree of photoaging, several agents
can be utilized to obtain superficial, medium-depth or
deep peeling of the skin.
Mild to moderate photodamaged skin is treated with
several superficial peeling agents such as alpha hydroxy
acids (AHA) in concentrations of 50–70%, or 50% thri-
chloracetic acid (TCA). They stimulate collagen produc-
tion. Salicylic acid 20–30% and pyruvic acid 40–70% also
showed beneficial results in treatment of advanced pho-
todamage of the neck and chest. Only irritation of upper
respiratory mucosa due to vapors of pyruvic acid and in-
tense stinging are reported disadvantages70,71.
TCA and phenol are used in the treatment of ad-
vanced photodamage. TCA in concentrations above 35%
has sometimes doubtful result as is quite unpredictable.
On the other hand, phenol peeling can cause serious car-
diac arrhythmias38. Combination of various agents are
recommended to enhance the efficacy of each other. So,
AHA 70% or Jessner solution with prior TCA 35% dam-
ages epidermal layer and enhance penetration of TCA in
deeper part of skin. So, combinations of AHA and TCA
35% is superior for the treatment of actinic keratosis in
comparison with Jessner solution and TCA 35%72. Histo-
logical specimens revealed decreased elastic fibers, in-
creased activity of fibroblasts and better collagen fibrile
organization. Also, 5% fluorouracil might be combined
with Jessner solution and TCA in severely UV-damaged
skin with actinic keratoses73. Advanatages and disadvan-
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tages of commonly used peels in practice are presented in
the Table 4, as well as instructions about the type of
chemical peels according to diagnosis and indication (Ta-
ble 5)1.
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SUVREMENI NA^INI LIJE^ENJA STARENJA KO@E
S A @ E T A K
Temeljni procesi uklju~eni u starenje ko`e su posljedica djelovanja ~imbenika iz okoli{a te naslje|enih ~initelja.
Pored toga, tzv. stohasti~ko starenje dovodi do stani~nog o{te}enja uzrokovanim metaboli~kim procesima, slobodnim
radikalima i kozmi~kim zra~enjem. Klini~ka slika starenja ko`e uzrokovanog naslje|em ili protokom vremena, uklju-
~uje glatku i tanku ko`u s nagla{enim linijama boranja. Starenje ko`e zbog djelovanja ~imbenika iz okoli{a uklju~uje
znakove fotoo{te}enja ko`e kao {to su pojava bora, pigmentiranih lezija, aktini~kih keratoza i mrljastih hipopigmen-
tacija. Za{tita od ultravioletnog (UV) zra~enja te upotreba antioksidansa kao {to su vitamin E i C, koenzim Q10, alfa
lipoi~na kiselina i glutation, mogu reducirati znakove starenja ko`e. Brojne studije potvr|uju u~inkovitost primjene
topi~kih agensa u kombinaciji s povr{nim i/ili srednje dubokih i dubokih peelinga u prevenciji fotoo{te}enja ko`e.
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